
Aeglea BioTherapeutics, Inc. Common Stock (AGLE) - Nasdaq
Find the latest Financials data for Aeglea BioTherapeutics, Inc. Common Stock (AGLE) at Nasdaq.com.
Aeglea BioTherapeutics (AGLE) Price Target Increased by 2435.
Oct 5, 2023 · The average one-year price target for Aeglea BioTherapeutics (NASDAQ:AGLE) has been revised to 18.10 / share. This is an increase of 2,435.71% from the prior estimate of …
Spyre Therapeutics, Inc. Common Stock (SYRE) - Nasdaq
Nov 1, 2025 · Discover real-time Spyre Therapeutics, Inc. Common Stock (SYRE) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay …
Aeglea BioTherapeutics, Inc. Common Stock (AGLE) - Nasdaq
Aeglea BioTherapeutics, Inc. Common Stock (AGLE) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
(AGLE) Latest Real Time Trades | Nasdaq
Volume: 0 Add to Watchlist Add to Portfolio Summary Real-Time After-Hours Pre-Market Charts News Press Releases Analyst Research AGLE AGLE REAL TIME AGLE LATEST REAL …
Diamondback Completes Acquisition of Double Eagle IV Holdings
Apr 2, 2025 · Diamondback completes the acquisition of Double Eagle IV, boosting its Midland Basin portfolio with 40,000 acres and enhancing its oil production capabilities.
Agnico Eagle Mines Limited Common Stock (AEM) - Nasdaq
Discover real-time Agnico Eagle Mines Limited Common Stock (AEM) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead …
Aeglea BioTherapeutics, Inc. Common Stock (AGLE) - Nasdaq
Find the latest news headlines from Aeglea BioTherapeutics, Inc. Common Stock (AGLE) at Nasdaq.com.
Eagle Energy Metals, Rightholder of the Largest Mineable
Jul 31, 2025 · --Eagle Energy Metals Corp., a next-generation nuclear energy company with rights to the largest mineable, measured and indicated uranium deposit in the United States and …
Eagle Point Credit Company Inc. Announces Third Quarter 2025
Sep 30, 2025 · Eagle Point Credit Company Inc. today announced financial results for the quarter ended September 30, 2025, and certain additional activity through October 31, 2025, and …